Kara Cannon
Chief Executive Officer, Director · ENZO BIOCHEM INC
Individual
- 2025
- Aug 20, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Kara Cannon's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kara Cannon?
Kara Cannon is a corporate insider, tracked as Chief Executive Officer, Director of ENZO BIOCHEM INC (ENZB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kara Cannon last file a Form 4?
The only primary Form 4 on record is dated 20 August 2025.
